Curebase optimizes patient retention rates in CNS studies by implementing validated engagement tactics.

Get the case study

In Curebase’s first international study, Quit Genius, a leading addiction digital clinic based in the United Kingdom was looking to test the preliminary effectiveness of a novel digital therapeutic intervention for smoking cessation. This treatment tool consisted of a digital therapeutic intervention via a smartphone app that delivered cognitive behavioral therapy, one-on-one coaching, craving tools, and more. In order to collect the necessary data over specific periods of time, Quit Genius enlisted Curebase’s decentralized clinical trial model.